El narco is a drug used to treat narcolepsy, which is a sleep disorder.
The brand is best known for its narcolesias, which are made with a combination of methamphetamine and marijuana.
El narco costs around $200 a dose, or around $50 for a 50mg dose, which the brand sells for $4.50 on Amazon.
The brand is currently listed as discontinued, but its brand name is also used as a brand name in the U.S. and Mexico.
The brand also sells products to treat other conditions, including chronic pain and epilepsy.
The product is available online and in some retail outlets.
El narcoma, which means “death of narco”, is a type of sleep disorder that affects a portion of the brain.
The label on El narcomacas drug labels says it has a “long-term effect on the central nervous system and nervous system function”.
The brand says its drug is available in Mexico for about $3.75 a dose.
El guapo, or “death from guapo”, is another drug with a “death effect” and is used for narcolytic narcozones, the drug used in narco-syndrome.
The drug is $4 a dose on Amazon and in pharmacies.
El pobre, or death from pain, is another type of narcomas painkiller.
It is a painkiller with a narcotic-like effect.
It costs around 10 cents a dose for 100mg on Amazon or $2.50 for 100g on Walmart.
The product has a similar label as the other two narcomazones.
El narcos is another brand of drug that has a label that says it is “safe and effective”.
It has a small amount of morphine in it.
The generic version of this drug, which does not contain any morphine, costs around 15 cents a dosage.
The DEA considers the brand generic.
The company says it uses a “complex process to create unique compounds that are not found in other pharmaceuticals.”
In a statement to El Narco, the brand says it was the most expensive drug on its shelves, and is still available.
The DEA said that its goal is to reduce drug abuse and improve public health.
The statement said its enforcement efforts will focus on those who use these products to sell drugs.
El Nuevo Sur was the first drug seized in the United States in 2018.